Skip to content
ChickenStockChickenStock
Research290650
L&C Bio logo

L&C Bio (290650) stock

KOSDAQ · Health Care Equipment & Supplies

KRW 19,560-2.93%(-590)

As of Nov 16, 11:21 AM KST

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-12.83x

Net loss — not comparable

P/B

5.90x

P/S

9.05x

Earnings

Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.

Quarters and year-to-date
PeriodRevenueOperating profitNet incomeRevenue YoY
Q2 2026Consolidated · Filed Aug 14, 2026KRW 38.8 billionKRW 8.6 billion-KRW 28.1 billion+89.2%
Q1 2026Consolidated · Filed May 15, 2026KRW 30.3 billionKRW 6 billionKRW 2.7 billion+70.6%
Q4 2025Consolidated · Filed Mar 24, 2026KRW 24.7 billionKRW 2 billion-KRW 72 billion—
Q3 2025Consolidated · Filed Nov 14, 2025KRW 22.6 billionKRW 2.9 billion-KRW 51.3 billion—
Q2 2025Consolidated · Filed Aug 14, 2025KRW 20.5 billionKRW 0-KRW 14.3 billion—
Q1 2025Consolidated · Filed May 15, 2025KRW 17.8 billion-KRW 400 million-KRW 600 million+7.2%
Fiscal years
PeriodRevenueOperating profitNet incomeRevenue YoY
FY2025Consolidated · Filed Mar 24, 2026KRW 85.5 billionKRW 4.4 billion-KRW 138.2 billion+18.6%
FY2024Consolidated · Filed Mar 21, 2025KRW 72.1 billionKRW 2.5 billionKRW 141 billion—
  • Q2 2026 is computed as H1 2026 minus Q1 2026.
  • Q4 2025 is computed as FY2025 minus 9M 2025.
  • Q3 2025 is computed as 9M 2025 minus H1 2025.
  • Q2 2025 is computed as H1 2025 minus Q1 2025.
Original filing (DART)

Short selling and securities lending

Short sales as a share of trading value, the reported short position and the securities lending balance.

Short-sale share
16.06%
Of trading value on Nov 13, 2026
Short-sale value
KRW 2.51 billion
Previous 20-day average 9.26%
Net short position
1,231,005 shares
As of Nov 11, 2026 · reported with a two-trading-day lag
Lending balance
7,262,907 shares
As of Nov 13, 2026 · 11.89% of listed shares
Recent short-sale days
DateShareValue
Nov 13, 202616.06%KRW 2.51 billion
Nov 12, 20264.81%KRW 1.11 billion
Nov 11, 202621.87%KRW 2.46 billion
Nov 10, 202620.90%KRW 2.46 billion
Nov 9, 20269.05%KRW 2.91 billion
Nov 6, 202613.18%KRW 1.17 billion
Nov 5, 202611.83%KRW 1.28 billion
Nov 4, 20267.06%KRW 420 million
Nov 3, 202611.93%KRW 500 million
Nov 2, 20263.36%KRW 300 million

The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.

L&C Bio (290650) stock information

KOSDAQ

L&C Bio (290650) is listed on KOSDAQ. Its market capitalization is about KRW 1.2 trillion. On trailing-twelve-month earnings the P/E ratio is -12.83, and the P/B ratio is 5.9. Return on equity is -46%. These figures are computed in-house from official filings and are reference information only.

L&C Bio — frequently asked questions

What is the P/E ratio of L&C Bio (290650)?
On a trailing-twelve-month basis, 290650 trades at a P/E ratio of -12.83. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of L&C Bio?
290650 has a market capitalization of about KRW 1.2 trillion. The figure moves with the share price and is refreshed each trading day.
Does L&C Bio pay a dividend?
290650 has a dividend yield of about 0.1%, based on disclosed payment history. Dividend policy can change; this is reference information only.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.